Neurobiology of Aging
Volume 29, Issue 1 , Pages 12-22 , January 2008

Cathepsin D expression is decreased in Alzheimer's disease fibroblasts

  • Lorena Urbanelli

      Affiliations

    • Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Via del Giochetto, Perugia 06126, Italy
    • ,
  • Carla Emiliani

      Affiliations

    • Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Via del Giochetto, Perugia 06126, Italy
    • ,
  • Carlo Massini

      Affiliations

    • Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Via del Giochetto, Perugia 06126, Italy
    • ,
  • Emanuele Persichetti

      Affiliations

    • Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Via del Giochetto, Perugia 06126, Italy
    • ,
  • Antonio Orlacchio

      Affiliations

    • Laboratorio di Neurogenetica, CERC-IRCCS Santa Lucia, Rome, Italy
    • Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome, Italy
    • ,
  • Giuliana Pelicci

      Affiliations

    • Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, Milan, Italy
    • ,
  • Sandro Sorbi

      Affiliations

    • Dipartimento di Scienze Neurologiche e Psichiatriche, Università di Firenze, Florence, Italy
    • ,
  • Andrej Hasilik

      Affiliations

    • Philipps-University Marburg, Marburg, Germany
    • ,
  • Giorgio Bernardi

      Affiliations

    • Laboratorio di Neurogenetica, CERC-IRCCS Santa Lucia, Rome, Italy
    • Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome, Italy
    • ,
  • Aldo Orlacchio

      Affiliations

    • Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Via del Giochetto, Perugia 06126, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 075 5857438; fax: +39 075 5857443.

Received 3 November 2005 ,Revised 22 August 2006 ,Accepted 14 September 2006.

References 

  1. Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience. 2000;100(3):663–675
  2. Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem. 2002;83:481–489[Review]
  3. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 1996;17:1005–1013
  4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  5. Cataldo AM, Nixon RA. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA. 1990;87(10):3861–3865
  6. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA. 1991;88(24):10998–11002
  7. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 1995;14(3):671–680
  8. Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S, et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med. 2002;33(10):1372–1379
  9. Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J, et al. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA. 1994;91(25):11993–11997
  10. Connolly GP. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol Sci. 1998;19(5):171–177
  11. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-α. EMBO J. 1996;15:3861–3870
  12. Demoz M, Castino R, Dragonetti A, Raitieri E, Baccino FM, Isidoro C. Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J Cell Biochem. 1999;73:370–378
  13. Demoz M, Castino R, Follo C, Hasilik A, Sloane BF, Isidoro C. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells. Protein Expr Purif. 2006;45(1):157–167
  14. Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem. 1989;264(23):13403–13406
  15. Dreyer RN, Bausch KM, Fracasso P, Hammond LJ, Wunderlich D, Wirak DO, et al. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur J Biochem. 1994;224(2):265–271
  16. Emiliani C, Urbanelli L, Racanicchi L, Orlacchio A, Pelicci G, Sorbi S, et al. Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation. J Biol Chem. 2003;278(40):38453–38460
  17. Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K, et al. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D. Biochemistry. 1995;34(43):14185–14192
  18. Fruitier I, Garreau I, Piot JM. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem Biophys Res Commun. 1998;246(3):719–724
  19. Gandy S, Petanceska S. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Biochim Biophys Acta. 2000;1502:44–52[Review]
  20. Gartner U, Holzer M, Arendt T. Induction of p21ras in Alzheimer pathology. Neuroreport. 1995;6:1441–1444
  21. Gartner U, Holzer M, Arendt T. Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience. 1999;91:1–5
  22. Gruninger-Leitch F, Berndt P, Langen H, Nelboeck P, Dobeli H. Identification of beta-secretase-like activity using a mass spectrometry-based assay system. Nat Biotechnol. 2000;18(1):66–70
  23. Isidoro C, Demoz M, De Stefanis D, Baccino FM, Hasilik A, Bonelli G. Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts. Int J Cancer. 1997;70(3):310–314
  24. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356[Review]
  25. Hazzalin CA, Cuenda A, Cano E, Cohen P, Mahadevan LC. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene. 1997;15(19):2321–2331
  26. Higaki J, Catalano R, Guzzetta AW, Quon D, Nave JF, Tarnus C, et al. Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem. 1996;271(50):31885–31893
  27. Hofmann SL, Peltonen L. The neuronal ceroid lipofuscinoses. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. 8th ed.. New York: McGraw-Hill; 2001;p. 3877–3894
  28. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, et al. Identification of a novel aspartic protease (Asp2) as beta-secretase. Mol Cell Neurosci. 1999;14(6):419–427
  29. Kagedal K, Johansson U, Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. 2001;15:1592–1594
  30. Kenessey A, Nacharaju P, Ko LW, Yen SH. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem. 1997;69(5):2026–2038
  31. Kalmes A, Deou J, Clowes AW, Daum G. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett. 1999;444(1):71–74
  32. Kohnken RE, Ladror US, Wang GT, Holzman TF, Miller BE, Krafft GA. Cathepsin D from Alzheimer's-diseased and normal brains. Exp Neurol. 1995;133(2):105–112
  33. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, et al. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci. 2000;20:6898–6906
  34. Lai MT, Crouthamel MC, DiMuzio J, Pietrak BL, Donoviel DB, Bernstein A, et al. A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage. J Neurochem. 2006;96(January (1)):118–125[Epub 2005 Nov 21]
  35. McKhann G, Drachman G, Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the department of health and human services task force on Alzheimer's disease. Neurology. 1984;34:939–944
  36. Nakanishi H. Neuronal and microglial cathepsins in aging and age-related diseases. Aging Res Rev. 2003;2(4):367–381
  37. Partanen S, Storch S, Loffler HG, Hasilik A, Tyynela J, Braulke T. A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. Biochem J. 2003;369:55–62
  38. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000;406(6792):207–210
  39. Rijnboutt S, Kal AJ, Geuze HJ, Aerts H, Strous GJ. Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. J Biol Chem. 1991;266:23586–23592
  40. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 1995;14:3599–3608
  41. Saftig P, Peters C, von Figura K, Craessaerts K, Van Leuven F, De Strooper B. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem. 1996;271(44):27241–27244
  42. Schwagerl AL, Mohan PS, Cataldo AM, Vonsattel JP, Kowall NW, Nixon RA. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J Neurochem. 1995;64(1):443–446
  43. Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?. Nat Rev Neurosci. 2002;3(4):281–290[Review]
  44. Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, et al. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett. 2005;579:2759–2766
  45. Tyynela J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, et al. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 2000;19:2786–2792
  46. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–741
  47. Wolf M, Clark-Lewis I, Buri C, Langen H, Lis M, Mazzucchelli L. Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Am J Pathol. 2003;162(4):1183–1190
  48. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398(6727):513–517
  49. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 1999;402(6761):533–537

PII: S0197-4580(06)00339-3

doi: 10.1016/j.neurobiolaging.2006.09.005

Neurobiology of Aging
Volume 29, Issue 1 , Pages 12-22 , January 2008

Article Tools

* Image Usage & Resolution